Literature DB >> 22594689

Early supported discharge after stroke in Bergen (ESD Stroke Bergen): a randomized controlled trial comparing rehabilitation in a day unit or in the patients' homes with conventional treatment.

Håkon Hofstad1, Halvor Naess, Rolf Moe-Nilssen, Jan Sture Skouen.   

Abstract

RATIONALE: As a result of demographic changes with a presumed rapidly increasing number of older people during the coming decades, a strong increase in the incidence and prevalence of stroke should be expected. Early supported discharge implies that the patients are discharged to their homes as soon as feasible and that rehabilitative treatment is offered after the discharge, with the patients being home-dwelling. This has proved beneficial in previous studies. AIMS: The main objective of this study is to further characterize the important components of early supported discharge and to confirm superiority of early supported discharge over conventional treatment. The secondary aim will be to compare two different early supported discharge schemes. These early supported discharge schemes are composed of intensive rehabilitation treatment given by a multidisciplinary team in a day unit and, alternatively, the same treatment given in the patients' homes.
DESIGN: The study is conducted as a randomized controlled trial with three arms: two different forms of early supported discharge and a control arm with conventional treatment. Patients with acute stroke admitted to our hospital's stroke unit and living in the Municipality of Bergen are considered for inclusion. A total of 350 stroke patients are expected. STUDY OUTCOMES: Primary outcome is modified Rankin Scale six-months after inclusion. Secondary outcomes include Barthel Index and National Institute of Health Stroke Scale at several points in time after inclusion, as well as many other schemes, questionnaires and physical tests. The study is registered in ClinicalTrials.gov registration number NCT00771771.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Keywords:  ESD; RCT; clinical trial; early supported discharge; rehabilitation; stroke

Mesh:

Year:  2012        PMID: 22594689     DOI: 10.1111/j.1747-4949.2012.00825.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  6 in total

Review 1.  Early supported discharge services for people with acute stroke.

Authors:  Peter Langhorne; Satu Baylan
Journal:  Cochrane Database Syst Rev       Date:  2017-07-13

2.  Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual.

Authors:  Håkon Hofstad; Bente Elisabeth Bassøe Gjelsvik; Halvor Næss; Geir Egil Eide; Jan Sture Skouen
Journal:  BMC Neurol       Date:  2014-12-21       Impact factor: 2.474

3.  Ability in daily activities after early supported discharge models of stroke rehabilitation.

Authors:  Tina Taule; Liv Inger Strand; Jörg Assmus; Jan Sture Skouen
Journal:  Scand J Occup Ther       Date:  2015-05-25       Impact factor: 2.611

4.  Communication and Relational Ties in Inter-Professional Teams in Norwegian Specialized Health Care: A Multicentre Study of Relational Coordination.

Authors:  Merethe Hustoft; Øystein Hetlevik; Jӧrg Aßmus; Sverre Størkson; Sturla Gjesdal; Eva Biringer
Journal:  Int J Integr Care       Date:  2018-04-27       Impact factor: 5.120

5.  Balance and walking after three different models of stroke rehabilitation: early supported discharge in a day unit or at home, and traditional treatment (control).

Authors:  Bente Elisabeth Bassøe Gjelsvik; Håkon Hofstad; Tori Smedal; Geir Egil Eide; Halvor Næss; Jan Sture Skouen; Bente Frisk; Silje Daltveit; Liv Inger Strand
Journal:  BMJ Open       Date:  2014-05-14       Impact factor: 2.692

6.  Subjective health complaints predict functional outcome six months after stroke.

Authors:  H Hofstad; H Naess; B E B Gjelsvik; G E Eide; J S Skouen
Journal:  Acta Neurol Scand       Date:  2016-06-26       Impact factor: 3.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.